Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). (March 2022) - Taylor, Sally; Tsim, Selina; Navani, Neal; Baldwin, David; Woolhouse, Ian; Edwards, John; Grundy, Seamus; Robson, Jonathan; Rhodes, Sarah; Burnside, Nathan; Blackhall, Fiona; Faivre-Finn, Corinne; et al.